Best Cannabis Stocks to Watch Right Now: Only 6 Names Show Real Strength While Most Remain in Breakdown Mode
Discover the 11 strongest buy-signal stocks right now and 12 weak names still stuck in clear downtrends. This technical breakdown highlights top breakout candidates, avoid-zone stocks, and the signals that matter most.
by Kowsalya
Published Apr 02, 2026 | Updated Apr 02, 2026 | 📖 8 min read
On This Page
- Quick answer: Which stocks look strongest right now?
- Best buy signals right now: the names standing out
- Secondary bullish names worth watching closely
- The biggest avoid zone: cannabis names still trapped in weak charts
- Cannabis stocks still showing weak technicals
- What about cannabis names that look slightly better?
- Featured snippet: What are the strongest stocks from this screen?
- Featured snippet: Which stocks should be avoided right now?
- How to read these signals the right way
- Best stocks by category
If you want the direct answer first, the strongest setups are PFE, JNJ, JAZZ, CRBP, INCY, MAPS, ATAI, BSBR, SBS, CIG, and VNRX. On the other side, several names still look technically weak and better avoided for now, including TLRY, SNDL, CGC, OGI, IIPR, HITI, TPST, IONQ, REFI, GNLN, MRMD, and AYRWF.
Markets often look healthier on the surface than they actually are underneath. This scan helps separate stocks with real momentum confirmation from those that are merely bouncing inside larger downtrends.
The most important takeaway is simple: a “buy” label alone is not enough. The better setups in your data are the ones backed by a combination of rising volume, bullish MACD behavior, improving directional signals, better relative trend structure, and stronger composite scores. Stocks that lack those factors, or still sit inside active death-cross trends, remain higher risk even after short-term green candles.
Quick answer: Which stocks look strongest right now?
Top technical buy candidates
- PFE
- JNJ
- JAZZ
- CRBP
- INCY
- MAPS
- ATAI
- BSBR
- SBS
- CIG
- VNRX
Stocks still in avoid or exit territory
- TLRY
- SNDL
- CGC
- OGI
- IIPR
- HITI
- TPST
- IONQ
- REFI
- GNLN
- MRMD
- AYRWF
Best buy signals right now: the names standing out
1) Pfizer (PFE) looks like the strongest overall setup
Pfizer ranks at the very top of the screen with a Strong Buy signal, the highest rank in the list, bullish MACD behavior, a golden-cross structure, and positive short-term and medium-term returns. It is also trading at its high rather than deeply below it, which is usually a healthier sign than a stock trying to recover from heavy technical damage.
The only caution is that the stock appears somewhat extended, with the note indicating that it may be better to wait for a pullback rather than chase aggressively.
Why PFE stands out
- Highest-ranked setup in the screen
- Bullish MACD
- Golden cross
- Positive 1-week, 1-month, and 3-month performance
- Stronger overall trend quality than most peers
2) Johnson & Johnson (JNJ) remains one of the cleanest defensive breakouts
JNJ also scores extremely well with a Strong Buy rating, bullish MACD, a golden cross, and steady relative strength. The stock is only slightly below its high, which suggests strength is holding up better than in most names on the list.
This is one of the more stable-looking setups in the screen, especially compared with the speculative trades.
3) Jazz Pharmaceuticals (JAZZ) combines momentum and trend confirmation
JAZZ is one of the strongest technical names in the data. It carries a Strong Buy rating, bullish MACD, bullish DI positioning, rising OBV, and solid recent returns. The stock is also much closer to its highs than most names shown in your table.
That combination makes it one of the most convincing bullish setups in the entire group.
4) Corbus Pharmaceuticals (CRBP) is a high-momentum breakout candidate
CRBP is more aggressive, but technically it is one of the clearest momentum names in the screen. It has a Strong Buy score, strong recent gains, bullish MACD, bullish directional setup, rising OBV, and a breakout-style profile.
The trade-off is obvious: this is a higher-volatility stock, so risk control matters more here than it would in large-cap pharma.
5) Incyte (INCY) is another strong biotech setup
INCY shows many of the same characteristics traders want to see in a healthier breakout candidate: bullish MACD, bullish directional setup, rising OBV, and a strong composite score. It may not be as explosive as CRBP, but it looks far cleaner than the majority of weak or neutral names in the list.
Secondary bullish names worth watching closely
MAPS is one of the better speculative entries
MAPS earns a Strong Buy with volume confirmation and a breakout-style signal. It is still well below long-term highs, which adds risk, but among the speculative names in this screen, it is one of the more constructive setups.
ATAI has improving momentum
ATAI also shows a Strong Buy signal with bullish MACD, bullish directional balance, and rising OBV. The structure is not perfect, but it is clearly stronger than most cannabis-linked laggards in the screen.
BSBR, SBS, and CIG show healthier trend behavior
These three names stand out because they have stronger recent performance, bullish MACD setups, and better trend structure than most of the list. They are not necessarily perfect low-risk entries, but they are clearly in much better technical shape than the avoid-zone names.
VNRX is a high-risk, high-volatility breakout
VNRX posts a Strong Buy and one of the highest confidence readings in the speculative group. The catch is obvious: very high volatility and weaker risk/reward quality. This is the kind of name that can move fast, but it is not the same class of setup as JNJ or PFE.
The biggest avoid zone: cannabis names still trapped in weak charts
The cannabis section of the screen is largely disappointing. While a few names show early momentum sparks, most still sit in weak trend structures, death-cross patterns, falling OBV, or negative composite scores.
Cannabis stocks still showing weak technicals
| Stock | Signal | Key problem |
|---|---|---|
| TLRY | Strong Sell | Active downtrend, death cross, weak momentum |
| SNDL | Strong Sell | Score -11, ADX confirms downtrend |
| CGC | Strong Sell | No entry, downtrend still active |
| OGI | Strong Sell | Weak structure, death cross remains |
| HITI | Strong Sell | No valid entry, downtrend active |
| AYRWF | Strong Sell | Strong downtrend, extreme weakness |
| MRMD | Strong Sell | Score -15, confirmed downtrend |
| GNLN | Strong Sell | Heavy recent collapse, ADX confirms trend damage |
| CURLF | Sell | No clean entry despite short-term bounce |
| TCNNF | Sell | Only partial condition count, weak reward setup |
| MSOS | Sell | Not enough bullish confirmation |
| YOLO | Sell | Trend still weak, risk/reward unattractive |
Why Tilray and SNDL still do not qualify as buys
Tilray and SNDL are two of the clearest examples of why oversold does not automatically mean attractive. Both names still carry poor composite scores, bearish MACD readings, weak directional structure, and death-cross behavior. In SNDL’s case, the note is especially blunt: strong downtrend, avoid.
That means any bounce in these names still looks more like a countertrend move than a reliable trend reversal.
CGC, OGI, and HITI also remain weak
These names have not done enough technically to move out of the avoid bucket. Their scores remain negative, price structure is still poor, and volume/trend confirmation is lacking.
What about cannabis names that look slightly better?
A few names are improving, but they still need caution.
CRON is early, not confirmed
CRON has a Hold rating and a more constructive structure than many peers, including a golden cross and bullish MACD turn. But it still has only a limited number of conditions met. That makes it more of a watchlist candidate than a high-conviction buy.
GRWG shows a strong signal, but the risk/reward is poor
GRWG is interesting because it has a Buy rating and meets many conditions. But the quoted risk/reward in your data is weak, which makes it harder to justify a fresh aggressive entry unless the setup improves.
JUSHF and RVVTF are speculative movers
These names show some technical improvement, but they remain highly speculative and volatile. For conservative readers, they do not belong in the same category as the stronger pharma and biotech setups.
Featured snippet: What are the strongest stocks from this screen?
The strongest technical setups in the provided data are PFE, JNJ, JAZZ, CRBP, INCY, MAPS, ATAI, BSBR, SBS, CIG, and VNRX because they show the best mix of bullish MACD signals, stronger composite scores, healthier volume behavior, and more constructive trend structures.
Featured snippet: Which stocks should be avoided right now?
The clearest avoid-zone names in the screen are TLRY, SNDL, CGC, OGI, IIPR, HITI, TPST, IONQ, REFI, GNLN, MRMD, and AYRWF because they still show active downtrends, negative scores, bearish technical structure, or confirmed trend weakness.
How to read these signals the right way
Bullish score alone is not enough
Some stocks in the table are labeled Strong Buy, but the note still warns that risk/reward is poor. That matters. A stock can have improving momentum while still offering a weak entry at current price levels.
The best setups usually share these traits
Stronger charts often have:
- Bullish MACD
- Rising OBV or volume confirmation
- Golden cross or improving moving-average structure
- Positive composite score
- Better recent return profile
- Smaller percentage drop from highs
Weak charts often have:
- Death cross
- Falling OBV
- Bearish DI positioning
- Negative score
- High ADX during a decline
- “No entry” or “avoid” notes
Best stocks by category
Best large-cap or defensive technical setups
- PFE
- JNJ
- JAZZ
- INCY
These names look stronger for readers who prefer relatively more established companies over pure speculation.
Best aggressive breakout candidates
- CRBP
- ATAI
- MAPS
- VNRX
These are higher-risk trades, but technically they are among the few speculative names with real momentum support.
Best names to keep on watch, not chase
- CRON
- GRWG
- TEVA
- WM
- ABBV
These are not broken charts, but they do not yet look like the strongest entries in this screen.
Disclaimer
This content is for informational purposes only and not financial advice. Stock market investments are subject to risk, and past performance does not guarantee future results. Always conduct your own research and consult a qualified financial advisor before investing. The analysis is based on available data and may change with market conditions.
Only 6 Names Show Real Strength While Most Remain in Breakdown Mode - FAQ's
1. Which cannabis stock looks strongest right now?
Based on the screener data you shared, CRBP stands out as the strongest technical setup, with one of the best composite scores, a breakout signal, and a high-conviction note.
2. Is TLRY a buy right now?
Based on the screener, TLRY is not a buy right now. It is marked Strong Sell, with a bearish structure, death cross, and an active downtrend note, even though the company recently reported stronger quarterly results.
3. Why is SNDL still an avoid?
SNDL still has a Strong Sell score, bearish MACD, a death-cross structure, and trend confirmation showing continued weakness. That combination suggests the stock is still in a downtrend rather than in a confirmed reversal.
4. Which stocks are better for conservative traders?
The more conservative technical setups in this list are PFE, JNJ, JAZZ, and INCY. These names look structurally stronger than the highly speculative small-cap or cannabis names.
5. Which stocks are better for aggressive traders?
More aggressive traders may focus on CRBP, ATAI, MAPS, and VNRX, which show stronger momentum characteristics but also carry much higher volatility.